Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Panacea Life Sciences's total debt was $125.69K at Mar 31, 2021. For fiscal 2020 it was $901.45K, up 384.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $901.45K | +384.9% |
| FY2019 | Dec 31, 2019 | $185.91K | -62.2% |
| FY2018 | Dec 31, 2018 | $491.79K | – |
| FY2017 | Dec 31, 2017 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021 | Mar 31, 2021 | $125.69K | -32.4% |
| Q4 FY2020 | Dec 31, 2020 | $901.45K | +83.3% |
| Q3 FY2020 | Sep 30, 2020 | $205.17K | – |
| Q2 FY2020 | Jun 30, 2020 | $244.76K | – |
| Q4 FY2019 | Dec 31, 2019 | $185.91K | – |
| Q4 FY2018 | Dec 31, 2018 | $491.79K | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
See a number that looks wrong?